These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 25902414

  • 1. MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model.
    Lee SY, Sin JI.
    Hum Vaccin Immunother; 2015; 11(8):2012-20. PubMed ID: 25902414
    [Abstract] [Full Text] [Related]

  • 2. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model.
    Ahn E, Kim H, Han KT, Sin JI.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):676-85. PubMed ID: 25449428
    [Abstract] [Full Text] [Related]

  • 3. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 4. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.
    Immunology; 2006 Aug 15; 118(4):483-96. PubMed ID: 16895556
    [Abstract] [Full Text] [Related]

  • 5. Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro.
    Correale P, Aquino A, Giuliani A, Pellegrini M, Micheli L, Cusi MG, Nencini C, Petrioli R, Prete SP, De Vecchis L, Turriziani M, Giorgi G, Bonmassar E, Francini G.
    Int J Cancer; 2003 Apr 20; 104(4):437-45. PubMed ID: 12584740
    [Abstract] [Full Text] [Related]

  • 6. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells.
    Dai S, Wan T, Wang B, Zhou X, Xiu F, Chen T, Wu Y, Cao X.
    Clin Cancer Res; 2005 Oct 15; 11(20):7554-63. PubMed ID: 16243831
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A, Chatterjee SK, Foon KA, Primus FJ, Sreedharan S, Mohanty K, Bhattacharya-Chatterjee M.
    Cancer Res; 2004 Jul 15; 64(14):4995-5003. PubMed ID: 15256474
    [Abstract] [Full Text] [Related]

  • 8. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
    Song K, Chang Y, Prud'homme GJ.
    Gene Ther; 2000 Sep 15; 7(18):1527-35. PubMed ID: 11021590
    [Abstract] [Full Text] [Related]

  • 9. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J.
    Clin Cancer Res; 2003 May 15; 9(5):1837-49. PubMed ID: 12738742
    [Abstract] [Full Text] [Related]

  • 10. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine.
    Huang Y, Fayad R, Smock A, Ullrich AM, Qiao L.
    Cancer Res; 2005 Aug 01; 65(15):6990-9. PubMed ID: 16061685
    [Abstract] [Full Text] [Related]

  • 11. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A, Chatterjee SK, Foon KA, Primus FJ, Bhattacharya-Chatterjee M.
    Cancer Res; 2003 Jun 01; 63(11):2844-54. PubMed ID: 12782590
    [Abstract] [Full Text] [Related]

  • 12. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
    Kudo-Saito C, Schlom J, Hodge JW.
    Clin Cancer Res; 2005 Mar 15; 11(6):2416-26. PubMed ID: 15788693
    [Abstract] [Full Text] [Related]

  • 13. Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.
    Schmitz J, Reali E, Hodge JW, Patel A, Davis G, Schlom J, Greiner JW.
    Cancer Res; 2002 Sep 01; 62(17):5058-64. PubMed ID: 12208761
    [Abstract] [Full Text] [Related]

  • 14. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Ishida K, Primus FJ, Yamaue H.
    Int J Cancer; 2007 Feb 01; 120(3):585-93. PubMed ID: 17096339
    [Abstract] [Full Text] [Related]

  • 15. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.
    Xiang R, Primus FJ, Ruehlmann JM, Niethammer AG, Silletti S, Lode HN, Dolman CS, Gillies SD, Reisfeld RA.
    J Immunol; 2001 Oct 15; 167(8):4560-5. PubMed ID: 11591784
    [Abstract] [Full Text] [Related]

  • 16. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
    Kobayashi H, Omiya R, Ruiz M, Huarte E, Sarobe P, Lasarte JJ, Herraiz M, Sangro B, Prieto J, Borras-Cuesta F, Celis E.
    Clin Cancer Res; 2002 Oct 15; 8(10):3219-25. PubMed ID: 12374692
    [Abstract] [Full Text] [Related]

  • 17. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM, Schlom J, Hodge JW.
    Cancer Res; 2002 Oct 15; 62(20):5770-7. PubMed ID: 12384537
    [Abstract] [Full Text] [Related]

  • 18. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K, Chang Y, Prud'homme GJ.
    Gene Ther; 2000 Mar 15; 7(6):481-92. PubMed ID: 10757021
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
    Tsang KY, Zhu M, Nieroda CA, Correale P, Zaremba S, Hamilton JM, Cole D, Lam C, Schlom J.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2439-49. PubMed ID: 9815645
    [Abstract] [Full Text] [Related]

  • 20. Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.
    Darcy PK, Haynes NM, Snook MB, Trapani JA, Cerruti L, Jane SM, Smyth MJ.
    J Immunol; 2000 Apr 01; 164(7):3705-12. PubMed ID: 10725729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.